A detailed history of Canandaigua National Corp transactions in Amgen Inc stock. As of the latest transaction made, Canandaigua National Corp holds 13,682 shares of AMGN stock, worth $4.38 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
13,682
Previous 12,928 5.83%
Holding current value
$4.38 Million
Previous $2.91 Million 23.3%
% of portfolio
0.61%
Previous 0.52%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

BUY
$229.03 - $291.01 $172,688 - $219,421
754 Added 5.83%
13,682 $3.59 Million
Q3 2022

Oct 05, 2022

BUY
$224.46 - $253.15 $145,001 - $163,534
646 Added 5.26%
12,928 $2.91 Million
Q2 2022

Jul 05, 2022

SELL
$230.71 - $256.74 $66,675 - $74,197
-289 Reduced 2.3%
12,282 $2.99 Million
Q1 2022

May 09, 2022

BUY
$219.27 - $242.57 $399,948 - $442,447
1,824 Added 16.97%
12,571 $3.04 Million
Q4 2021

Jan 04, 2022

BUY
$198.88 - $227.6 $44,946 - $51,437
226 Added 2.15%
10,747 $2.42 Million
Q3 2021

Oct 04, 2021

SELL
$212.27 - $248.7 $46,699 - $54,714
-220 Reduced 2.05%
10,521 $2.24 Million
Q2 2021

Jul 06, 2021

BUY
$233.58 - $259.14 $43,679 - $48,459
187 Added 1.77%
10,741 $2.62 Million
Q1 2021

Apr 05, 2021

SELL
$221.91 - $258.6 $443 - $517
-2 Reduced 0.02%
10,554 $2.63 Million
Q4 2020

Feb 11, 2021

BUY
$216.38 - $257.67 $23,801 - $28,343
110 Added 1.05%
10,556 $2.43 Million
Q3 2020

Oct 19, 2020

SELL
$234.65 - $260.95 $510,129 - $567,305
-2,174 Reduced 17.23%
10,446 $2.66 Million
Q2 2020

Jul 07, 2020

BUY
$197.81 - $242.74 $2.5 Million - $3.06 Million
12,620 New
12,620 $2.98 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Canandaigua National Corp Portfolio

Follow Canandaigua National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canandaigua National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Canandaigua National Corp with notifications on news.